Hoxton Financial’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$36K Sell
500
-650
-57% -$49.2K 0.02% 167
2015
Q4
$97K Sell
1,150
-1,500
-57% -$124K 0.05% 95
2015
Q3
$222K Buy
2,650
+650
+33% +$54.9K 0.11% 72
2015
Q2
$167K Hold
2,000
0.07% 91
2015
Q1
$145K Hold
2,000
0.06% 93
2014
Q4
$138K Hold
2,000
0.06% 100
2014
Q3
$130K Hold
2,000
0.06% 95
2014
Q2
$124K Hold
2,000
0.05% 97
2014
Q1
$118K Buy
2,000
+300
+18% +$16.7K 0.05% 100
2013
Q4
$87K Sell
1,700
-1,045
-38% -$52.3K 0.04% 167
2013
Q3
$138K Sell
2,745
-264
-9% -$13.8K 0.13% 52
2013
Q2
$148K Buy
+3,009
New +$164K 0.08% 83

Other funds holding LLY

Hoxton Financial's LLY Position: Q1 2016 in Review

Hoxton Financial reduced its Eli Lilly (LLY) stake by 57% in Q1 2016, selling an estimated $49.2K and leaving 500 shares worth $36K. The position accounts for 0.02% of the portfolio, ranked #167.

Hoxton Financial first reported a position in LLY in Q2 2013 and has held it in 12 quarters since. The position peaked at $222K in Q3 2015. 1,152 funds tracked by Wall St. Rank hold LLY as of Q1 2016.

  • Hoxton Financial held 500 shares of Eli Lilly worth $36K as of Q1 2016.
  • Hoxton Financial sold 650 Eli Lilly shares in Q1 2016, an estimated $49.2K.
  • Eli Lilly made up 0.02% of Hoxton Financial's portfolio in Q1 2016, its #167 holding.
  • Hoxton Financial first reported a position in Eli Lilly in Q2 2013 and has held it in 12 quarters since.
  • Hoxton Financial's Eli Lilly position peaked at $222K in Q3 2015.
  • 1,152 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2016.

Based on Hoxton Financial's 13F filing for Q1 2016, filed 29 Apr 2016.